TrialAnnals of hematology2021

Cereblon expression is a prognostic marker in newly diagnosed POEMS syndrome treated with lenalidomide plus dexamethasone.

Qian-Qian Cai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.